Local μ and δ opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum

Neuroscience

Volumn 121, Issue 2, 2003, Pages 387-398

  Gonzalez Nicolini, M V ^a   Berglind, W ^a   Cole, K S ^a   Keogh, C L ^a   McGinty, J F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

CTAP; Naltrindole; Preprodynorphin; Preproenkephalin; Substance P; TIPP

Indexed keywords

AMPHETAMINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; MESSENGER RNA; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NEUROPEPTIDE; PREPRODYNORPHIN; PREPROENKEPHALIN; SUBSTANCE P;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG INFUSION; GENE EXPRESSION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE;

EID: 0141756265     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00488-3     Document Type: Article

References (60)

1. Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Rev. 19:1994;1-28.
2. Balcells-Olivero M., Vezina P. Effects of naltrexone on amphetamine-induced locomotion and rearing acute and repeated injections . Psychopharmacology (Berl). 131:1997;230-238.
3. Bals-Kubik R., Shippenberg T.S., Herz A. Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. Eur J Pharmacol. 175:1990;63-69.
4. Calabresi P., De Murtas M., Bernardi G. The neostriatum beyond the motor function experimental and clinical evidence . Neuroscience. 78:1997;39-60.
5. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol. 44:1993;8-12.
6. + conductance of rat locus ceruleus neurons. Mol Pharmacol. 50:1996;650-655.
7. Dalia A., Uretsky N.J., Wallace L.J. Dopaminergic agonists administered into the nucleus accumbens effects on extracellular glutamate and on locomotor activity . Brain Res. 788:1998;111-117.
8. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release in vivo microdialysis studies . J Pharmacol Exp Ther. 266:1993;1236-1246.
9. Diaz-Otanez C.S., Capriles N.R., Cancela L.M. D1 and D2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine. Pharmacol Biochem Behav. 58:1997;9-14.
10. Evans C.J., Keith D.E. Jr, Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
11. Florin S.M., Kuczenski R., Segal D.S. Amphetamine induces changes in behavior and caudate extracellular acetylcholine. Brain Res. 581:1992;53-58.
12. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H. Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. FEBS Lett. 327:1993;311-314.
13. Garrett B.E., Holtzman S.G. Comparison of the effects of prototypical behavioral stimulants on locomotor activity and rotational behavior in rats. Pharmacol Biochem Behav. 54:1996;469-477.
14. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors generation of novel functional properties . J Biol Chem. 275:2000;26128-26135.
15. Georges F., Stinus L., Bloch B., Le Moine C. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci. 11:1999;481-490.
16. Gerfen C.R. The neostriatal mosaic I. Compartmental organization of projections from the striatum to the substantia nigra in the rat . J Comp Neurol. 236:1985;454-456.
17. Gerfen C.R., Young W.S.I.I.I. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments an in situ hybridization histochemistry and fluorescent retrograde tracing study . Brain Res. 460:1988;161-167.
18. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20:RC110.
19. Gonzalez-Nicolini M.V., McGinty J.F. NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res. 931:2002;41-49.
20. Gray A.M., Rawls S.M., Shippenberg T.S., McGinty J.F. The kappa opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. J Neurochem. 73:1999;1066-1074.
21. Guggenheim N.D., Klop H., Minami M., Satoh M., Voorn P. Co-localization of μ receptor is greater with dynorphin than enkephalin in rat striatum. Neuroreport. 7:1996;2119-2124.
22. Guix T., Hurd Y.L., Ungerstedt U. Amphetamine enhances extra-cellular concentrations of dopamine and acetycholine in dorsolateral striatum and nucleus accumbens of freely moving rats. Neurosci Lett. 138:1992;137-140.
23. Heidbreder C., Goldberg S.R., Shippenberg T.S. Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole. Eur J Pharmacol. 243:1993;123-127.
24. Hirakawa N., Tershner S.A., Fields H.L. Highly selective delta selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO. Neuroreport. 10:1999;3125-3129.
25. Holt D.J., Graybiel A.M., Saper C.B. Neurochemical architecture of the human striatum. J Comp Neurol. 384:1997;1-25.
26. Hooks M.S., Jones D.N., Justice J.B. Jr, Holtzman S.G. Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol Biochem Behav. 42:1992;765-770.
27. Jones D.N., Bowen W.D., Portoghese P.S., Holtzman S.G. Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. Eur J Pharmacol. 249:1993;167-177.
28. Jones D.N., Holtzman S.G. Influence of naloxone upon motor activity induced by psychomotor stimulant drugs. Psychopharmacology (Berl). 114:1994;215-224.
29. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The delta-opioid receptor isolation of a cDNA by expression cloning and pharmacological characterization . Proc Natl Acad Sci USA. 89:1992;12048-12052.
30. Kramer T.H., Shook J.E., Kazmierski W., Ayres E.A., Wire W.S., Hruby V.J., Burks T.F. Novel peptidic mu opioid antagonists pharmacologic characterization in vitro and in vivo . J Pharmacol Exp Ther. 249:1989;544-551.
31. Kuzmin A.V., Gerrits M.A., van Ree J.M., Zvartau E.E. Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice. Life Sci. 60:(PL-257-):1997;264.
32. Lubetzki C., Chesselet M.F., Glowinski J. Modulation of dopamine release in rat striatal slices by delta opiate agonists. J Pharmacol Exp Ther. 222:1982;435-440.
33. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci. 7:1987;2445-2464.
34. Mansour A., Hoversten M.T., Taylor L.P., Watson S.J., Akil H. The cloned mu, delta and kappa receptors and their endogenous ligands evidence for two opioid peptide recognition cores . Brain Res. 700:1995;89-98.
35. Meshul C.K., McGinty J.F. Kappa opioid receptor immunoreactivity in nucleus accumbens shell and caudate-putamen is primarily associated with synaptic vesicles in axons. Neuroscience. 2000:1999;91-99.
36. Meyer M.E., Meyer M.E. Behavioral effects of the mu-opioid peptide agonists DAMGO, DALDA, and PL017 on locomotor activities. Pharmacol Biochem Behav. 46:1993;391-395.
37. Mulder A.H., Wardeh G., Hogenboom F., Frankhuyzen A.L. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 308:1984;278-280.
38. Negri L., Improta G., Lattanzi R., Potenza R.L., Luchetti F., Melchiorri P. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4] deltorphin in supraspinal antinociception and delta-opioid receptor binding. Br J Pharmacol. 116:1995;2931-2938.
39. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia I. The cortico-basal ganglia-thalamo-cortical loop . Brain Res Rev. 20:1995;91-127.
40. Paxinos G., Watson C. The rat brain in stereotoxic coordinates. San DiegoAcademic Press. 1986.
41. Rawls S.M., McGinty J.F. Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum an in vivo microdialysis study . Brain Res. 861:2000;296-304.
42. Romita V.V., Henry J.L. Spinal mu, delta, and kappa-opioid receptors mediate intense stimulation-elicited inhibition of a nociceptive reflex in the rat. Eur J Pharmacol. 357:1998;127-138.
43. Romualdi P., Lesa G., Donatini A., Ferri S. Long-term exposure to opioid antagonists up-regulates prodynorphin gene expression in rat brain. Brain Res. 672:1995;42-47.
44. Sala M., Braida D., Colombo M., Groppetti A., Sacco S., Gori E., Parenti M. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J Pharmacol Exp Ther. 274:1995;450-457.
45. Schad C.A., Justice J.B. Jr, Holtzman S.G. Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine. Eur J Pharmacol. 275:1995;9-16.
46. Schad C.A., Justice J.B. Jr, Holtzman S.G. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem. 67:1996;2292-2299.
47. Schiller P.W., Weltrowska G., Nguyen T.M., Wilkes B.C., Chung N.N., Lemieux C. TIPP[psi] a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity . J Med Chem. 36:1993;3182-3187.
48. Shippenberg T.S., Bals-Kubik R., Herz A. Motivational properties of opioids evidence that an activation of delta-receptors mediates reinforcement processes . Brain Res. 436:1987;234-239.
49. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA. 89:1992;2046-2050.
50. Svingos A.L., Clarke C.L., Pickel V.M. Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell implications for opiate and psychostimulant cross-sensitization . Synapse. 34:1999;1-10.
51. Svingos A.L., Clarke C.L., Pickel V.M. Cellular sites for activation of D-opioid receptors in the rat nucleus accumbens shell relationship with met5-enkephalin . J Neurosci. 18:1998;1923-1933.
52. Tempel A., Kessler J.A., Zukin S. Chronic naltrexone treatment increases expression of preproenkephalin and preprotachykinin mRNA in discrete brain regions. J Neurosci. 10:1990;741-747.
53. Tzaferis J.A., McGinty J.F. Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Mol Brain Res. 93:2001;27-35.
54. Wang H., Pickel V.M. Preferential cytoplasmic localization of D-opioid receptors in rat striatal patches comparison with plasmalemmal μ-opioid receptors . J Neurosci. 21:2001;3242-3250.
55. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R. Mu opiate receptor cDNA cloning and expression . Proc Natl Acad Sci USA. 90:1993;10230-10234.
56. Wang J.Q., McGinty J.F. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following the acute injection of amphetamine and methamphetamine. Synapse. 22:1996;114-122.
57. Wang J.Q., McGinty J.F. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J Pharmacol Exp Ther. 273:1995;909-917.
58. Wang J.Q., McGinty J.F. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Mol Brain Res. 54:1998;262-269.
59. Yasuda K., Raynor K., Kong H., Breder C.D., Takeda J., Reisine T., Bell G.I. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci USA. 90:1993;6736-6740.
60. Zhu Y., King M.A., Schuller A.G., Nitsche J.F., Reidl M., Elde R.P., Unterwald E., Pasternak G.W., Pintar J.E. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron. 24:1999;243-252.